TREA

Scribe Therapeutics, Inc.

Follow

Organization

  • Alameda, CA, US
Organizations

Patents Grantslast 30 patents

  • Information Patent Grant

    Guide scaffolds
    • Patent number 12,084,692
    • Issue date Sep 10, 2024
    • Scribe Therapeutics Inc.
    • Benjamin Oakes
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Particle delivery systems
    • Patent number 11,976,277
    • Issue date May 7, 2024
    • Scribe Therapeutics Inc.
    • Jason Fernandes
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Compositions and methods for the targeting of SOD1
    • Patent number 11,613,742
    • Issue date Mar 28, 2023
    • Scribe Therapeutics Inc.
    • Benjamin Oakes
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Engineered proteins
    • Patent number 11,560,555
    • Issue date Jan 24, 2023
    • Scribe Therapeutics Inc.
    • Benjamin Oakes
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Compositions and methods for the targeting of rhodopsin
    • Patent number 11,535,835
    • Issue date Dec 27, 2022
    • Scribe Therapeutics Inc.
    • Benjamin Oakes
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

  • Information Patent Application

    ENGINEERED CASX REPRESSOR SYSTEMS
    • Publication number 20240392271
    • Publication date Nov 28, 2024
    • Scribe Therapeutics Inc.
    • Jason FERNANDES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS
    • Publication number 20240376462
    • Publication date Nov 14, 2024
    • Scribe Therapeutics Inc.
    • Gayathri VIJAYAKUMAR
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    SELF-INACTIVATING VECTORS FOR GENE EDITING
    • Publication number 20240360474
    • Publication date Oct 31, 2024
    • Scribe Therapeutics Inc.
    • Katherine BANEY
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF C9orf72
    • Publication number 20240309344
    • Publication date Sep 19, 2024
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    ENGINEERED CLASS 2, TYPE V REPRESSOR SYSTEMS
    • Publication number 20240254466
    • Publication date Aug 1, 2024
    • Scribe Therapeutics Inc.
    • Jason FERNANDES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS OF GLYCOPROTEIN PARTICLES
    • Publication number 20240207196
    • Publication date Jun 27, 2024
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9
    • Publication number 20240123089
    • Publication date Apr 18, 2024
    • Scribe Therapeutics Inc.
    • Jason FERNANDES
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9
    • Publication number 20240124537
    • Publication date Apr 18, 2024
    • Scribe Therapeutics Inc.
    • Jason FERNANDES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
    • Publication number 20240101984
    • Publication date Mar 28, 2024
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF PTBP1
    • Publication number 20240100185
    • Publication date Mar 28, 2024
    • Scribe Therapeutics Inc.
    • Susan TOM
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    AAV VECTORS FOR GENE EDITING
    • Publication number 20240033377
    • Publication date Feb 1, 2024
    • Scribe Therapeutics Inc.
    • Manuel MOHR
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A
    • Publication number 20240026386
    • Publication date Jan 25, 2024
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS
    • Publication number 20240026385
    • Publication date Jan 25, 2024
    • Scribe Therapeutics Inc.
    • Gayathri VIJAYAKUMAR
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    PARTICLE DELIVERY SYSTEMS
    • Publication number 20230183691
    • Publication date Jun 15, 2023
    • Scribe Therapeutics Inc.
    • Jason FERNANDES
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9
    • Publication number 20230167424
    • Publication date Jun 1, 2023
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    GUIDE SCAFFOLDS
    • Publication number 20230124880
    • Publication date Apr 20, 2023
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
    • Publication number 20230081117
    • Publication date Mar 16, 2023
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS
    • Publication number 20230054437
    • Publication date Feb 23, 2023
    • Scribe Therapeutics Inc.
    • Gayathri VIJAYAKUMAR
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF HTT
    • Publication number 20230032369
    • Publication date Feb 2, 2023
    • Scribe Therapeutics, Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF RHODOPSIN
    • Publication number 20230033866
    • Publication date Feb 2, 2023
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
    • Publication number 20220348925
    • Publication date Nov 3, 2022
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ENGINEERED CASX SYSTEMS
    • Publication number 20220220508
    • Publication date Jul 14, 2022
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    DEEP MUTATIONAL EVOLUTION OF BIOMOLECULES
    • Publication number 20220177872
    • Publication date Jun 9, 2022
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
    • Publication number 20220090036
    • Publication date Mar 24, 2022
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    ENGINEERED PROTEINS
    • Publication number 20220081681
    • Publication date Mar 17, 2022
    • Scribe Therapeutics Inc.
    • Benjamin OAKES
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Trademarklast 30 trademarks

  • Information Trademark

    97761836 - ELXR
    • Serial number 97761836
    • Filing date Jan 20, 2023
    • Scribe Therapeutics Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    97761835 - ELXR
    • Serial number 97761835
    • Filing date Jan 20, 2023
    • Scribe Therapeutics Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97473474 - X SCRIBE THERAPEUTICS
    • Serial number 97473474
    • Filing date Jun 23, 2022
    • Scribe Therapeutics Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    97473473 - X SCRIBE THERAPEUTICS
    • Serial number 97473473
    • Filing date Jun 23, 2022
    • Scribe Therapeutics Inc.
    • 44 - Medical services
  • Information Trademark

    97473476 - X SCRIBE THERAPEUTICS
    • Serial number 97473476
    • Filing date Jun 23, 2022
    • Scribe Therapeutics Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97420511 - SCRIBE THERAPEUTICS
    • Serial number 97420511
    • Filing date May 20, 2022
    • Scribe Therapeutics Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90596751 - CRISPR BY DESIGN
    • Serial number 90596751
    • Filing date Mar 23, 2021
    • Scribe Therapeutics Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    88188800 - SCRIBE
    • Serial number 88188800
    • Registration number 6775193
    • Filing date Nov 9, 2018
    • Scribe Therapeutics Inc.
    • 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...
Count: 2

Research Projects